about
Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune responseEnhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85ADetection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.DNA vaccination: the answer to stable, protective T-cell memory?Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infectionHalf-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis.Shaping the CD4+ memory immune response against tuberculosis: the role of antigen persistence, location and multi-functionality.The Memory Immune Response to Tuberculosis.Geographical differences in the proportion of human group A rotavirus strains within New Zealand during one epidemic season.IL-1βR-dependent priming of antitumor CD4(+) T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria.Identification of potential CD8+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice.Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand.Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years.Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.BCG vaccination drives accumulation and effector function of innate lymphoid cells in murine lungs.Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice.Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo.Langerin+ CD8α+ Dendritic Cells Drive Early CD8+ T Cell Activation and IL-12 Production During Systemic Bacterial Infection.Accelerating the secondary immune response by inactivating CD4+CD25+ T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosisInactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen loadSustained in vivo depletion of splenic langerin+ CD8α+ dendritic cells is well-tolerated by lang-DTREGFP miceGr1 Cells Dominate the Early Phagocyte Response to Mycobacterial Lung Infection in MiceIL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in miceWhich is the true regulator of TH2 cell development in allergic immune responses?Constitutive expression of interleukin 4 in vivo does not lead to the development of T helper 2 type CD8+ T cells secreting interleukin 4 or interleukin 5TCR- or Cytokine-Activated CD8+ Mucosal-Associated Invariant T Cells Are Rapid Polyfunctional Effectors That Can Coordinate Immune ResponsesImmunological memoryInnovative antigen carrier system for the development of tuberculosis vaccinesBeyond memory T cells: mechanisms of protective immunity to tuberculosis infection
P50
Q34438532-35D76971-1A00-4AFE-845A-0281A9573443Q34531924-C960DF7B-04DE-4A64-AAF0-57919B880A4FQ34784058-C0B78D33-98D7-49E0-8DD8-839E43F80289Q35192616-CE386ABB-7A70-4E8A-8D1C-EF569C3514B7Q36369774-E4FDC3F5-0DC8-4A29-BD66-67B66162D69BQ36919069-C2716DA6-35E3-4A50-B80D-0EA3316D4128Q38273050-FA0E1AB7-F564-4337-B95F-5F2A0FACA219Q39020828-5AFCAF07-8D51-431C-88FB-AAC093824699Q39889027-9D056BB6-97A9-491A-A3FD-A9BF28AC1BCEQ40449413-B6402EAF-90EE-4C9B-8D00-38FF57F61530Q44477644-FE557626-7FE6-4CC7-AF62-75F1BFE910ABQ45398006-98EF1316-E702-4A1F-BD3C-593EDF6534ACQ45413095-B8A7B6DD-4E63-4D2F-8EB7-478FEA364091Q45854493-1C47DCD2-CD4A-47E0-A60A-96452B714B5FQ47715600-E0A65BF1-D574-4F7C-B6C7-701F5F42D415Q50949144-B16EC7C4-D335-4FA3-AC8D-314F74E3B082Q52011176-491F5C87-A082-4924-ADE2-B777E1C9C3E4Q55527143-B71B4A69-AC49-4C03-B4BD-DA0AAEED7DADQ59050547-507FECB7-D138-4F43-A415-59D086A327A3Q59050560-7B06FF9F-8507-47BF-BC3B-E22EE1C830BAQ62230645-16596A57-8495-4D8E-9DE4-FDBB04FB3EEBQ64114567-F581AC5E-AFDD-48EE-937E-D0344F92F78DQ74467274-0909AD38-095D-4CF7-87B1-3892C78E8E01Q77358064-099C9DE4-532B-4069-955A-007B7D488164Q78053724-FE40FDF3-080B-44C1-A957-750E628FD4CAQ90162776-332252C3-AE1E-43FB-BFC1-E89F87B25B98Q91710307-121F131A-E8A9-4E89-9AAF-5B8DBE8B50EBQ92355501-9947CD28-ACF2-4983-A8DC-534124112AC1Q92372145-0072D011-B467-4BE6-9652-1DE3CAD1BCC3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joanna R Kirman
@ast
Joanna R Kirman
@en
Joanna R Kirman
@es
Joanna R Kirman
@nl
type
label
Joanna R Kirman
@ast
Joanna R Kirman
@en
Joanna R Kirman
@es
Joanna R Kirman
@nl
prefLabel
Joanna R Kirman
@ast
Joanna R Kirman
@en
Joanna R Kirman
@es
Joanna R Kirman
@nl
P106
P1153
55934463200
P31
P496
0000-0002-4802-7048